Literature DB >> 371882

Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).

H Warnatz, W Rösch, W Gerlich, W Gutmann.   

Abstract

A new technique using HBsAg-coated Chang cells as target cells was developed in order to measure cell-mediated immune reactions to HBsAg. The specificity of cytotoxic reactions was tested in experiments using Chang cells conjugated with human serum albumin. Antibody-dependent cell-mediated cytotoxicity (ADCC) specific for the HBsAg-coated target cells was demonstrated up to dilutions of anti-HBsAg serum of 10,000 : 1, when lymphocytes from the peripheral blood of normal individuals were added to the target cells. Spontaneous cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells was demonstrated for lymphocytes from patients with hepatitis B and from patients with chronic active hepatitis (CAH), but not for lymphocytes from healthy controls. The CMC of hepatitis B lymphocytes to HBsAg-coated target cells was inhibited in the presence of antiserum to HBsAg. In experiments using purified lymphocyte populations evidence is presented that the CMC is T-cell dependent. HLA-restriction of the CMC was not observed. The described cytotoxicity test system has the advantage that target cells conjugated with defined antigens are used and that relevant control target cells are available.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 371882      PMCID: PMC1537592     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Immunoglobulin-binding factor present on and produced by thymus-processed lymphocytes (T cells).

Authors:  W H Fridman; P Golstein
Journal:  Cell Immunol       Date:  1974-03-30       Impact factor: 4.868

2.  Antibody in the induction and inhibition of lymphocyte cytotoxicity.

Authors:  I C MacLennan
Journal:  Transplant Rev       Date:  1972

3.  Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells.

Authors:  P Perlmann; H Perlmann; H Wigzell
Journal:  Transplant Rev       Date:  1972

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Binding of sheep red blood cells to a large population of human lymphocytes.

Authors:  W H Lay; N F Mendes; C Bianco; V Nussenzweig
Journal:  Nature       Date:  1971-04-23       Impact factor: 49.962

6.  Studies on lymphocytotoxicity in acute and chronic liver disease.

Authors:  H Warnatz; W Gutmann; W Rösch; G Hommel
Journal:  Z Immunitatsforsch Immunobiol       Date:  1977-12

7.  "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.

Authors:  R Kiessling; E Klein; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

8.  Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.

Authors:  F Paronetto; S Vernace
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

9.  Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen.

Authors:  G C de Gast; B Houwen; H O Nieweg
Journal:  Br Med J       Date:  1973-12-22

10.  Cellular and humoral response to transplantation antigens. I. Development of alloantibody-forming cells and cytotoxic lymphocytes in the graft-versus-host reaction.

Authors:  J C Cerottini; A A Nordin; K T Brunner
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

View more
  10 in total

1.  [Follow-up study on antibody dependent cell-mediated cytotoxicity and cell-mediated cytotoxicity to HBs-antigen conjugated target cells in patients with hepatitis B (author's transl)].

Authors:  H Warnatz; W Gerlich; W Gutmann; R Werntges
Journal:  Klin Wochenschr       Date:  1980-11-17

2.  Interaction of lymphocytes with hepatocytes containing hepatitis B antigen: ultrastructural demonstration of target antigen and T-cell subsets by the peroxidase antibody technique.

Authors:  H Sasaki; T Kojima; S Matsui; K Aoyama; K Inoue
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.

Authors:  H F Eggink; H J Houthoff; S Huitema; G Wolters; S Poppema; C H Gips
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

4.  Clinically important immunological processes in acute and fulminant hepatitis, mainly due to hepatitis B virus.

Authors:  M K Mackenjee; P Kiepiela; R Cooper; H M Coovadia
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

5.  Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.

Authors:  K Yoshioka; S Kakumu; H Murakami; K Fukui
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

6.  Hepatitis B surface antigen specific cytotoxic T lymphocyte activity in hepatitis B virus infection.

Authors:  S Onishi; T Saibara; K Ito
Journal:  Gastroenterol Jpn       Date:  1985-08

7.  Studies on immunoregulatory mechanisms in acute and chronic hepatitis B.

Authors:  G Lemm; K Salzer; H Warnatz
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

8.  Spontaneous cell-mediated (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) in patients with acute and chronic active hepatitis.

Authors:  T H Hütteroth; T Poralla; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1981-06-15

9.  Delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepatitis.

Authors:  S Nagafuchi; S Kashiwagi; S Hayashi; T Inoue; S Imayama; M Takeshita; M Kikuchi
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

Review 10.  The immunopathogenesis of chronic HBV induced liver disease.

Authors:  G A Levy; F V Chisari
Journal:  Springer Semin Immunopathol       Date:  1981-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.